CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers.

Front Immunol · 2020 · PMC7174602 · PMID 32351498

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Accordingly, the coinciding increase of CD73 in PDAC cells may be significant in promoting extracellular adenosine-mediated immunosuppression.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.